skip to navigation skip to content

 

BBC Radio 4: Today programme

Reporter Joe Lynam covers AstraZeneca & Pfizer deal and speaks with Richard Mason, CEO of XO1 Ltd and a fellow in Health Management at Cambridge Judge Business School. Richard discusses what role Cambridge plays in new drugs development. Listen from about 2 hrs 11 mins.

Listen to the podcast [bbc.co.uk]